Tenofovir disoproxil aspartate

Drug Profile

Tenofovir disoproxil aspartate

Alternative Names: CKD-390

Latest Information Update: 23 Jun 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Chong Kun Dang
  • Class Antiretrovirals; Antivirals; Phosphonic acids; Purines; Small molecules
  • Mechanism of Action Nucleotide reverse transcriptase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Hepatitis B

Most Recent Events

  • 01 Apr 2016 Phase-III clinical trials in Hepatitis B treatment in South Korea (PO) (NCT02805738)
  • 01 Dec 2015 Chong Kun Dang completes a phase I trial in Hepatitis B (In volunteers) in South Korea (PO) (NCT02589457)
  • 01 Oct 2015 Phase-I clinical trials in Hepatitis B treatment (In volunteers) in South Korea (PO) (NCT02589457)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top